Medivolve Inc. Stock
Stocks
MEDVF
CA58503M4083
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
OTC Markets
14:50:30 2026-08-10 EDT
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | -.--% |
|
-.--% | +9,900.00% |
| 05-11 | Osc reaches settlements with Stan Bharti and Neil Said, former executives of Medivolve Inc. | RE |
| 24-08-30 | Medivolve Inc. Announces Resignation of David Preiner as Chief Executive Officer | CI |
| Market Cap | 233K 166K 145K 136K 124K 15.85M 233K 1.63M 631K 8.1M 623K 609K 26.1M | P/E 2022 |
-0.19x | P/E 2023 | -0.02x |
|---|---|---|---|---|---|
| Enterprise Value | 898K 639K 558K 524K 479K 61.04M 898K 6.29M 2.43M 31.17M 2.4M 2.35M 100M | EV / Sales 2022 |
22,007x | EV / Sales 2023 | 1,535,308x |
| Free-Float |
94.14% | Yield 2022 * |
-
| Yield 2023 | - |
| 3 months | +9,900.00% | ||
| Current year | +9,900.00% |
| Current year | 0 | 0 | |
| 1 year | 0 | 0 | |
| 3 years | 0 | 0.05 | |
| 5 years | 0 | 3 | |
| 10 years | 0 | 10.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Evan Veryard
IRC | Investor Relations Contact | - | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 4/4/24 | Tax | Chief Executive Officer | 6,203,788 | 22.9606% | ||
| 2/21/24 | Option | 750,000 | 2.7758% | |||
| 2/21/24 | Buy | 750,000 | 2.7758% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | +9,900.00% | -99.67% | 2.7K | ||
| -0.15% | -1.79% | -6.08% | +28.40% | 42.31B | ||
| -0.75% | -0.65% | -47.55% | +127.07% | 12.32B | ||
| -0.78% | -4.49% | -13.77% | +104.67% | 5.54B | ||
| -0.32% | +1.27% | +52.59% | - | 4.38B | ||
| +0.46% | +9.12% | - | - | 2.23B | ||
| +2.28% | -1.01% | +5.84% | -35.04% | 1.48B | ||
| -2.25% | +0.97% | -36.01% | - | 1.06B | ||
| +0.20% | -2.34% | +17.88% | +151.76% | 989M | ||
| -0.90% | +1.84% | +37.79% | +51.75% | 905M | ||
| Average | -0.22% | +0.10% | +1,101.19% | +46.99% | 7.12B | |
| Weighted average by Cap. | -0.28% | -0.95% | -9.67% | +54.96% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 37.18 26.43 23.09 21.71 19.81 2.53K 37.18 260.5 100.52 1.29K 99.24 97.07 4.16K | 0.69 0.49 0.43 0.4 0.37 46.65 0.69 4.81 1.86 23.82 1.83 1.79 76.8 |
| Net income | -18.37M -13.06M -11.41M -10.72M -9.79M -1.25B -18.37M -129M -49.66M -637M -49.03M -47.95M -2.05B | -16.46M -11.7M -10.22M -9.61M -8.77M -1.12B -16.46M -115M -44.5M -571M -43.94M -42.97M -1.84B |
| Net Debt | -2.64M -1.88M -1.64M -1.54M -1.41M -180M -2.65M -18.53M -7.15M -91.79M -7.06M -6.91M -296M | 665K 473K 413K 388K 354K 45.19M 665K 4.66M 1.8M 23.08M 1.78M 1.74M 74.4M |
Employees
25
- Stock Market
- Stocks
- MEDVF Stock
Select your edition
All financial news and data tailored to specific country editions
















